{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:03:12Z","timestamp":1791482592562,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neurol.2026.02.159","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:34:07Z","timestamp":1776458047000},"page":"528-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study"],"prefix":"10.1016","volume":"182","author":[{"given":"C.","family":"Desnuelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Couratier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Corcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Duburcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Torreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Baffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nevoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Turgeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurol.2026.02.159_bib0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature","volume":"41","author":"Chi\u00f2","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"7\u20138","key":"10.1016\/j.neurol.2026.02.159_bib0215","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/21678421.2020.1779298","article-title":"Focus on the heterogeneity of amyotrophic lateral sclerosis","volume":"21","author":"Bendotti","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"10.1016\/j.neurol.2026.02.159_bib0220","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1007\/s00415-024-12435-9","article-title":"Update on recent advances in amyotrophic lateral sclerosis","volume":"271","author":"Riva","year":"2024","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2026.02.159_bib0225","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population-based study","volume":"82","author":"Chio","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.neurol.2026.02.159_bib0230","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1474-4422(16)30199-5","article-title":"Amyotrophic lateral sclerosis: moving towards a new classification system","volume":"15","author":"Al-Chalabi","year":"2016","journal-title":"Lancet Neurol"},{"issue":"5\u20136","key":"10.1016\/j.neurol.2026.02.159_bib0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review","volume":"10","author":"Chi\u00f2","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"issue":"10360","key":"10.1016\/j.neurol.2026.02.159_bib0240","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"issue":"10107","key":"10.1016\/j.neurol.2026.02.159_bib0245","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"issue":"Pt 3","key":"10.1016\/j.neurol.2026.02.159_bib0255","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/brain\/awr351","article-title":"A proposed staging system for amyotrophic lateral sclerosis","volume":"135","author":"Roche","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2026.02.159_bib0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp-2013-306589","article-title":"Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis","volume":"86","author":"Chi\u00f2","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Supplement 1","key":"10.1016\/j.neurol.2026.02.159_bib0265","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.respe.2016.01.079","article-title":"Algorithmes d\u2019identification des maladies neurod\u00e9g\u00e9n\u00e9ratives dans les bases de donn\u00e9es m\u00e9dico-administratives fran\u00e7aises\u00a0: revue de la litt\u00e9rature","volume":"64","author":"Gardette","year":"2016","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2026.02.159_bib0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/21678421.2016.1241280","article-title":"Validity of medico-administrative data related to amyotrophic lateral sclerosis in France: a population-based study","volume":"18","author":"Vasta","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"10.1016\/j.neurol.2026.02.159_bib0275","doi-asserted-by":"crossref","first-page":"e70156","DOI":"10.1111\/ene.70156","article-title":"Time trends in incidence of motor neuron diseases in france: a comprehensive 14-year nationwide study (2010\u20132023)","volume":"32","author":"Guinebretiere","year":"2025","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2026.02.159_bib0280","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neurol.2022.05.004","article-title":"Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: the French population-based register of ALS in Limousin (FRALim register)","volume":"178","author":"Luna","year":"2022","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"10.1016\/j.neurol.2026.02.159_bib0285","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neurol.2023.09.004","article-title":"Epidemiology of myasthenia gravis in France: a retrospective claims database study (STAMINA)","volume":"180","author":"Salort-Campana","year":"2024","journal-title":"Rev Neurol (Paris)"},{"issue":"11","key":"10.1016\/j.neurol.2026.02.159_bib0290","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1007\/s00415-024-12714-5","article-title":"Treatment of myasthenia gravis in France: a retrospective claims database study (STAMINA)","volume":"271","author":"Tard","year":"2024","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2026.02.159_bib0295","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","article-title":"Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2026.02.159_bib0300","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","article-title":"Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review","volume":"101","author":"Wolfson","year":"2023","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2026.02.159_bib0305","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10198-021-01328-7","article-title":"The economic burden of amyotrophic lateral sclerosis: a systematic review","volume":"22","author":"Achtert","year":"2021","journal-title":"Eur J Health Econ"},{"issue":"5\u20136","key":"10.1016\/j.neurol.2026.02.159_bib0310","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/21678421.2023.2165947","article-title":"Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review","volume":"24","author":"Berry","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2026.02.159_bib0315","unstructured":"Haute Autorit\u00e9 de sant\u00e9. HAS decision on RILUTEK. Available at: https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-13805_RILUTEK_CT13805_17092014_PIS_RI_Avis1.pdf [accessed 28 August 2025]."},{"key":"10.1016\/j.neurol.2026.02.159_bib0320","unstructured":"Haute Autorit\u00e9 de sant\u00e9. HAS decision on EMYLIF. Available at: https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-20126_EMYLIF_PIS_INS_AvisDef_CT20126.pdf [accessed 28 August 2025]."},{"key":"10.1016\/j.neurol.2026.02.159_bib0325","unstructured":"European Medicines Agency. EMA decision. Available at: https:\/\/www.ema.europa.eu\/en\/news\/new-treatment-rare-motor-neurone-disease-recommended-approval [accessed 28 August 2025]."},{"issue":"Suppl 4","key":"10.1016\/j.neurol.2026.02.159_bib411","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the Syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.neurol.2026.02.159_bib0330","unstructured":"FilSLAN, fili\u00e8re nationale de sant\u00e9 maladies rares : scl\u00e9rose lat\u00e9rale amyotrophique et maladies du neurone moteur. Available at: https:\/\/portail-sla.fr\/filiere-filslan\/ [accessed 28 August 2025]."},{"key":"10.1016\/j.neurol.2026.02.159_bib0340","doi-asserted-by":"crossref","first-page":"117054","DOI":"10.1016\/j.jns.2020.117054","article-title":"Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis","volume":"417","author":"Richards","year":"2020","journal-title":"J Neurol Sci"},{"issue":"5\u20136","key":"10.1016\/j.neurol.2026.02.159_bib0355","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/21678421.2014.932382","article-title":"Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses","volume":"15","author":"Gladman","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2026.02.159_bib0350","article-title":"The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: a population-based study of consultations, interventions and costs","volume":"126","author":"Galvin","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurol.2026.02.159_bib0335","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf292","article-title":"Epidemiology, disease evolution and economic burden of amyotrophic lateral sclerosis in France using the French national health data system","volume":"7","author":"Corcia","year":"2025","journal-title":"Brain Commun"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2026.02.159_bib0345","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/21678421.2017.1363242","article-title":"Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance","volume":"19","author":"Meng","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"10.1016\/j.neurol.2026.02.159_bib0365","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13023-020-01413-9","article-title":"Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany","volume":"15","author":"Sch\u00f6nfelder","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2026.02.159_bib0360","unstructured":"https:\/\/www.ispor.org\/heor-resources\/presentations-database\/presentation-cti\/ispor-europe-2025\/poster-session-5-2\/the-economic-burden-of-amyotrophic-lateral-sclerosis-an-observational-study-of-out-of-pocket-expenses-and-the-impact-on-caregivers [accessed 17 February 2026]."},{"issue":"8","key":"10.1016\/j.neurol.2026.02.159_bib0370","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10198-021-01328-7","article-title":"The economic burden of amyotrophic lateral sclerosis: a systematic review","volume":"22","author":"Achtert","year":"2021","journal-title":"Eur J Health Econ"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2026.02.159_bib0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/21678421.2014.932384","article-title":"Investigating the economic burden of ALS in Greece: a cost-of-illness approach","volume":"16","author":"Athanasakis","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"10.1016\/j.neurol.2026.02.159_bib0380","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00415-009-5256-6","article-title":"Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy","volume":"257","author":"Schepelmann","year":"2010","journal-title":"J Neurol"},{"issue":"5\u20136","key":"10.1016\/j.neurol.2026.02.159_bib0385","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/21678421.2023.2165947","article-title":"Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review","volume":"24","author":"Berry","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"10.1016\/j.neurol.2026.02.159_bib0390","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s00415-021-10508-7","article-title":"Prognostic models for amyotrophic lateral sclerosis: a systematic review","volume":"268","author":"Xu","year":"2021","journal-title":"J Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2026.02.159_bib0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurol.2026.02.159_bib0400","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neurol.2018.09.017","article-title":"Staging amyotrophic lateral sclerosis: a new focus on progression","volume":"175","author":"Corcia","year":"2019","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2026.02.159_bib0405","doi-asserted-by":"crossref","first-page":"120764","DOI":"10.1016\/j.jns.2023.120764","article-title":"Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: results from a real-world survey","volume":"452","author":"Stenson","year":"2023","journal-title":"J Neurol Sci"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726005035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726005035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:42:01Z","timestamp":1781282521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378726005035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0035378726005035"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2026.02.159","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2026.02.159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}